Publications 2005 [References 216–249]

216. McIntyre PB, Kelly HA, Mulholland EK. Immunisation at the crossroads: 9th National Immunisation / 1st Asia-Pacific Vaccine Preventable Diseases Conference [conference report]. Medical Journal of Australia 2005;182:15-6. [Full text]

217. Gilbert GL, Gidding HF, Backhouse J, McIntyre PB. Varicella seroprevalence and vaccine uptake in preschool children [letter]. Medical Journal of Australia 2005;182:42. [Full text]

218. Gidding HF. The impact of Australia’s measles control programme over the past decade. Epidemiology and Infection 2005;133:99-105. [Abstract]

219. Horby PW, Williams A, Burgess MA, Wang H. Prevalence and determinants of influenza vaccination in Australians aged 40 years and over – a national survey. Australian and New Zealand Journal of Public Health 2005;29:35-7. [Abstract]

220. Gidding HF, Backhouse JL, Gilbert GL, Burgess MA. National serosurvey of poliovirus immunity in Australia, 1996–99. Australian and New Zealand Journal of Public Health 2005;29:48-52. [Abstract]

221. McIntyre P, Lester R. Chapter 47. Immunisation. In: Yung AP, McDonald MI, Spelman DW, et al (eds). Infectious diseases: a clinical approach. 2nd ed. Melbourne: IP Communications; 2005.

222. Leask J, Leask S, Silove NS. Evidence for autism in folklore? Archives of Disease in Childhood 2005;90:271. [No abstract available]

223. McIntyre PB, Menzies RI. Immunisation: reducing health inequality for Indigenous Australians. Medical Journal of Australia 2005;182:207-8. [Full text]

224. Cagney M, MacIntyre CR, McIntyre PB, Peat J. Childhood asthma diagnosis and use of asthma medication. Australian Family Physician 2005;34:193-6. [Abstract]

225. Horby P, MacIntyre CR, McIntyre PB, Gilbert GL, Staff M, Hanlon M, Cagney M, Bennett C. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiology and Infection 2005;133:229-36. [Abstract]

226. Isaacs D, Lawrence G, Boyd I, Ronaldson K, McEwen J. Reporting of adverse events following immunisation in Australia. Journal of Paediatrics and Child Health 2005;41:163-6. [Abstract]

227. McIntyre PB, MacIntyre CR, Gilmour R, Wang H. A population-based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Archives of Disease in Childhood 2005;90:391-6. [Abstract]

228. MacIntyre CR, Kelly H, Jolley D, Butzkueven H, Salmon D, Halsey N, Moulton LH. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study [letter]. Neurology 2005;64:1317. [No abstract available]

229. Brotherton JML, Hull BP, Hayen A, Gidding HF, Burgess MA. Probability of coincident vaccination in the 24 or 48 hours preceding sudden infant death syndrome death in Australia. Pediatrics 2005;115:643-6. [Abstract]

230. Isaacs D, McIntyre P. Influenza vaccines in healthy children [letter]. Lancet 2005;365:2086. [No abstract available]

231. Cagney M, MacIntyre CR, McIntyre P, Torvaldsen S, Melot V. Cough symptoms in children aged 5–14 years in Sydney, Australia: non-specific cough or unrecognised pertussis? Respirology 2005;10:359-64. [Abstract]

232. Schmitt HJ, Siegrist CA, Salmaso S, Law B, Booy R. Unexplained cases of sudden infant death shortly after hexavalent vaccination [letter]. Vaccine 2005 July 21; [Epub ahead of print]. [No abstract available]

233. Burgess M, Forrest J, Jones CA, McIntyre P. Congenital rubella. In: Elliott E, Cronin P, Rose D, Zurynski Y, editors. Australian Paediatric Surveillance Unit Surveillance Report 2002-2003. Sydney: APSU; 2005. p.26-7.[Full text]

234. Jones CA, Isaacs D, McIntyre P, Cunningham T, Garland S. Neonatal herpes simplex virus infection (HSV). In: Elliott E, Cronin P, Rose D, Zurynski Y, editors. Australian Paediatric Surveillance Unit Surveillance Report 2002-2003. Sydney: APSU; 2005. p.41-3.[Full text]

235. Macartney K, McIntyre P. Universal varicella vaccination [letter]. Medical Journal of Australia 2005;183:278-9. [Full text]

236. Gidding HF, Backhouse JL, Burgess MA, Gilbert GL. Immunity to diphtheria and tetanus in Australia: a national serosurvey. Medical Journal of Australia 2005;183:301-4. [Ful text]

237. Lawrence GL, Boyd I, McIntyre PB, Isaacs D. Annual report: surveillance of adverse events following immunisation in Australia, 2004. Communicable Diseases Intelligence 2005;29:248-62. [Full text]

238. Andrews RM, Skull SA, Byrnes GB, Campbell DA, Turner JL, McIntyre PB, Kelly HA. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Communicable Diseases Intelligence 2005;29:283-8. [Full text]

239. Wood N, Backhouse J, Gidding HF, Gilbert GL, Lum G, McIntyre PB. Estimates of chronic hepatitis B virus infection in the Northern Territory. Communicable Diseases Intelligence 2005;29:289-90. [[Full text]

240. Joseph T, Menzies R, McIntyre P. Vaccination of Indigenous adults in the Community Controlled Sector – what is done and what works. In: Jackson Pulver L, McDermott D (eds). Djiadi #1.1 Revised monograph of the inaugural Indigenous Health Research Day. Muru Marri Indigenous Health Unit, Monograph Series. Sydney: University of NSW; 2005. p.69-71.

241. Menzies R, Williams K, McIntyre P. Measuring vaccination coverage in Aboriginal and Torres Strait Islander children. In: Jackson Pulver L, McDermott D (eds). Djiadi #1.1 Revised monograph of the inaugural Indigenous Health Research Day. Muru Marri Indigenous Health Unit, Monograph Series. Sydney: University of NSW; 2005. p.73-6.

242. McIntyre P. Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries? In: Pollard AJ, Finn A (eds). Hot topics in infection and immunity in children II. Series in: Advances in Experimental Medicine and Biology 2005;568:189-9. [Abstract]

243. Macartney KK, Beutels P, McIntyre P, Burgess MA. Varicella vaccination in Australia. Journal of Paediatrics and Child Health 2005;41:544-52. [Abstract]

244. Gidding HF, Brisson M, MacIntyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005;29:544-51. [Abstract]

245. Beutels P. Economic aspects of vaccines and vaccination: global perspective. In: Kaufmann SHE, Lambert PH (eds). The grand challenge for the future: vaccines for poverty-related diseases from bench to field. Basel: Birkhäuser Publishers; 2005.

246. Wood N, Menzies R, McIntyre P. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. Internal Medicine Journal 2005;35:530-5. [Abstract]

247. Welte R, Trotter C, Edmunds J, Postma M, Beutels P. The role of economic evaluation in vaccine decision making: focus on meningococcal C conjugate vaccine. Pharmacoeconomics 2005;23:855-74. [Abstract]

248. Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005. Communicable Diseases Intelligence 2005;29:413-6. [Full text]

249. Blows S, Macartney K, Campbell-Lloyd S. Bug Breakfast in the Bulletin: Varicella zoster. NSW Public Health Bulletin 2005;16:204-5. [Full text]